Please login to the form below

Not currently logged in
Email:
Password:

Dr Michael Mehler joins leon-nanodrugs as CEO

He succeeds Dr Ted Odlaug

leon-nanodrugs Michael MehlerMunich-headquartered leon-nanodrugs has appointed Dr Michael Mehler as chief executive officer, succeeding Dr Ted Odlaug who moves to the supervisory board.

Dr Mehler brings over 25 years of leadership experience in the pharma and biotech industries, most recently as chief executive of SpePharm, a Switz specialty hospital products developer.

Prior to this, he was chief executive officer of Riemser Pharma, and held a number of positions at Actelion Pharmaceuticals, Merck & Co and Novartis.

Dr Hubert Birner, chairman of the leon-nanodrugs board, said: “We welcome Michael to lead leon nanodrugs on our joint journey to continued growth and internationalisation.

“We know Michael as a very experienced executive and look forward to working with him.

“We would also like to express our sincere appreciation to Ted who did a tremendously impressing job - he will obviously bring his valuable expertise to the board in his new role and continue to complement our management team.”

18th January 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....
Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
...